Cargando…
Platelet count as a screening tool for compensated cirrhosis in chronic viral hepatitis
BACKGROUND: Simple tools for clinicians to identify cirrhosis in patients with chronic viral hepatitis are medically necessary for treatment initiation, hepatocellular cancer screening and additional medical management. AIM: To determine whether platelets or other laboratory markers can be used as a...
Autores principales: | Surana, Pallavi, Hercun, Julian, Takyar, Varun, Kleiner, David E, Heller, Theo, Koh, Christopher |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Baishideng Publishing Group Inc
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8160599/ https://www.ncbi.nlm.nih.gov/pubmed/34084591 http://dx.doi.org/10.4291/wjgp.v12.i3.40 |
Ejemplares similares
-
Validation of the albumin-bilirubin score for identifying decompensation risk in patients with compensated cirrhosis
por: Navadurong, Huttakan, et al.
Publicado: (2023) -
Natural history and outcomes of patients with liver cirrhosis complicated by hepatic hydrothorax
por: Romero, Sarah, et al.
Publicado: (2022) -
Proton pump inhibitor use increases mortality and hepatic decompensation in liver cirrhosis
por: De Roza, Marianne Anastasia, et al.
Publicado: (2019) -
Nonselective beta-blocker use is associated with increased hepatic encephalopathy-related readmissions in cirrhosis
por: Fallahzadeh, Mohammad Amin, et al.
Publicado: (2022) -
Distinct histological patterns in chronic hepatitis D with nucleos(t)ide analogue therapy
por: Hercun, Julian, et al.
Publicado: (2023)